
No data
No data
No data
| CAS Number | 79559-97-0 |
| Catalog Number | AG003U8P(AGN-PC-0UEQGK) |
| Chemical Name | Sertraline hydrochloride |
| IUPAC Name | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride |
| InChI | InChI=1S/C17H17Cl2N.ClH/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11;/h2-6,8,10,12,17,20H,7,9H2,1H3;1H/t12-,17-;/m0./s1 |
| InChI Key | BLFQGGGGFNSJKA-XHXSRVRCSA-N |
| MDL Number | MFCD00895772 |
| Molecular Formula | C17H18Cl3N |
| Molecular Weight | 342.6905 |
| SMILES | CN[C@H]1CC[C@H](C2=CC=CC=C21)C3=CC(Cl)=C(Cl)C=C3.[H]Cl |
| UNII | UTI8907Y6X |
| Synonyms | Altruline,
Apo Sertraline,
Apo-Sertraline,
Aremis,
Besitran,
Gen Sertraline,
Gen-Sertraline,
Gladem,
Hydrochloride, Sertraline,
Lustral,
Novo Sertraline,
Novo-Sertraline,
ratio Sertraline,
ratio-Sertraline,
Rhoxal sertraline,
Rhoxal-sertraline,
Sealdin,
Sertraline,
Sertraline Hydrochloride,
Sertraline Hydrochloride (1S-cis)-Isomer,
Zoloft,
Sertraline hydrochloride,
79559-97-0,
Sertraline HCl,
Zoloft,
Gladem,
Serad,
Atruline,
Tresleen,
Tatig,
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride,
Sertraline (hydrochloride),
UNII-UTI8907Y6X,
Lustral,
(+)-sertraline hydrochloride,
Cp 51,974-1,
(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride,
CHEBI:9124,
UTI8907Y6X,
MFCD00895772,
(1S,4S)-1-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-4-(methylamino)naphthalene Hydrochloride,
CPD000466298,
CP-51974-1,
(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthylamine hydrochloride,
DSSTox_CID_20243,
DSSTox_RID_79456,
DSSTox_GSID_40243,
79617-95-1,
rac-cis-Sertraline Hydrochloride,
Adjuvin,
C17H18Cl3N,
MLS001401398,
(+)-cis-(1S,4S)-1-methylamino-4-(3,4-dichlorophenyl)tetralin hydrochloride,
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-aminium chloride,
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride,
(1S-cis)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride,
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride, (1S-cis)-,
CAS-79559-97-0,
NCGC00092386-03,
SMR000466298,
SERTRALINE HYDRECHLORIDE,
CP-519741,
(+/-)-Sertraline Hydrochloride,
Serlift,
Aremis,
sertraline-hcl,
Sertraline.HCl,
Sertraline hydrochloride [USAN],
Sertraline, HCl,
Sertraline hydrochloride [USAN:USP],
Zoloft (TN),
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride,
79617-99-5,
Sertraline Impurity G HCl,
C17H17Cl2N.HCl,
CHEMBL1709,
SCHEMBL23230,
MLS000758929,
SERTALINE HYDROCHLORIDE,
ARONIS24360,
SPECTRUM1505262,
AC1L1Y71,
DTXSID1040243,
CTK8E2603,
HY-B0176A,
AOB2376,
BLFQGGGGFNSJKA-XHXSRVRCSA-N,
CP-51974-1 HCl,
HMS1922P09,
Pharmakon1600-01505262,
KS-00000H1Y,
Tox21_111199,
Tox21_500870,
AC-740,
CCG-39575,
CS0024,
NSC746308,
NSC758948,
SBB080777,
Sertraline hydrochloride (JAN/USAN),
AKOS005267232,
AKOS015846322,
Tox21_111199_1,
AB07662,
CS-2052,
KS-1111,
LP00870,
MCULE-1681469163,
NC00198,
NC00726,
NE57257,
NSC-746308,
NSC-758948,
NCGC00092386-01,
NCGC00092386-13,
NCGC00261555-01,
AN-15588,
BC216562,
BR-72966,
Cp-51,974-1,
LS-94166,
SAM001246666,
SAM001247100,
SAM002700175,
SC-16255,
Sertraline Hydrochloride (1S-cis)-Isomer,
Sertraline hydrochloride, >=98% (HPLC),
TL8005382,
TR-031501,
CP-5197401,
EU-0100870,
FT-0641726,
S0507,
S4053,
ST24031612,
D00825,
J10439,
559S970,
I14-16426,
Sertraline Hydrochloride 1.0 mg/ml in Methanol (as free base),
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-tetralin-1-amine hydrochloride,
Sertraline hydrochloride, British Pharmacopoeia (BP) Reference Standard,
Sertraline hydrochloride, European Pharmacopoeia (EP) Reference Standard,
(1S,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl(methyl)amine hydrochloride,
[(1S,4S)-4-(3,4-dichlorophenyl)(1,2,3,4-tetrahydronaphthyl)]methylamine, chlor ide,
1-naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-,(1S-cis)-,
Sertraline for peak identification, European Pharmacopoeia (EP) Reference Standard,
Sertraline for system suitability, European Pharmacopoeia (EP) Reference Standard,
Sertraline hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(1 s-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphathalenamine hydrochloride,
(1s-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphathalenamine hydrochloride,
[(1S,4S)-4-(3,4-DICHLORO-PHENYL)-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YL]-METHYL-AMINE HYDROCHLORIDE,
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride,(1S-cis)-,
rac-Sertraline Hydrochloride ((1RS,4RS)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine Hydrochloride),
Sertraline hydrochloride racemic mixture, United States Pharmacopeia (USP) Reference Standard,
Sertraline hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material,
sertraline,
Sertraline enantiomer,
Sertraline, cis-(-)-,
UNII-CVO48CMI7U,
CP-51973 hydrochloride,
Sertraline, (1R,4R)-,
UNII-H0905KBO3H,
(R,R)-Sertraline hydrochloride,
C17-H17-Cl2-N.Cl-H,
CID63009,
Sertraline hydrochloride, cis-(-)-,
Sertraline hydrochloride, (1R,4R)-,
CB10386,
CS-O-08151,
CP-51973,
B2257,
Sertraline hydrochloride specified impurity G [EP],
Sertraline hydrochloride impurity, (R,R) sertraline-,
79617-96-2,
4- -1,2,3,4-tetrahydro-N-methyl-1-naphthalenaminehydrochloride,
79617-89-3,
79645-15-1,
Sertraline hydrochloride impurity, (R,R) sertraline hydrochloride- [USP],
(1R,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine,
[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenyl]methylamine hydrochloride,
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4R)-,
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R-cis)-,
4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride,
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride (1:1), (1R,4R)-,
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride, (1R-cis)-,
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride, (1S,4S)-,
79617-98-4,
Sertraline hydrochloride, 98%, an antidepressant of the selective serotonin reuptake inhibitor (SSRI) - 1G 1g,
|
| Complexity | 322 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 2 |
| Defined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 341.05g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 21 |
| Hydrogen Bond Acceptor Count | 1 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 342.688g/mol |
| Monoisotopic Mass | 341.05g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 12A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Symbol: | |
| Hazard Class | 9 |
| Hazard statements | H315-H319-H335 |
| Packing Group | Ⅲ |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | UN 3077 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

